HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomohide Tsukahara Selected Research

HLA-B55 antigen

4/2019Identification of novel human leukocyte antigen-A*11:01-restricted cytotoxic T-lymphocyte epitopes derived from osteosarcoma antigen papillomavirus binding factor.
8/2014Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.
6/2009HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomohide Tsukahara Research Topics

Disease

72Neoplasms (Cancer)
05/2024 - 08/2004
18Sarcoma (Soft Tissue Sarcoma)
10/2023 - 08/2005
16Osteosarcoma (Osteogenic Sarcoma)
10/2023 - 01/2003
9Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 06/2011
9Neoplasm Metastasis (Metastasis)
09/2023 - 01/2013
7Colonic Neoplasms (Colon Cancer)
09/2023 - 06/2011
7Carcinoma (Carcinomatosis)
07/2023 - 10/2016
6Testicular Neoplasms (Testicular Cancer)
01/2023 - 01/2016
6Synovial Sarcoma (Synovioma)
09/2012 - 08/2002
4Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 10/2020
4Lung Neoplasms (Lung Cancer)
01/2017 - 02/2005
3Squamous Cell Carcinoma of Head and Neck
09/2023 - 05/2020
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2023 - 01/2017
3Melanoma (Melanoma, Malignant)
04/2023 - 02/2005
3Carcinogenesis
01/2021 - 01/2017
3Pancreatic Neoplasms (Pancreatic Cancer)
08/2019 - 01/2013
2Breast Neoplasms (Breast Cancer)
11/2023 - 04/2017
2Urinary Bladder Neoplasms (Bladder Cancer)
07/2023 - 04/2022
2Granuloma
06/2023 - 03/2021
2COVID-19
04/2023 - 01/2023
2Microsatellite Instability
01/2022 - 01/2017
2Tuberculosis (Tuberculoses)
03/2021 - 01/2021
2Adenocarcinoma of Lung
11/2020 - 01/2013
2Adenocarcinoma
08/2019 - 01/2017
2Hypoxia (Hypoxemia)
12/2016 - 05/2015
1Stomach Neoplasms (Stomach Cancer)
05/2024
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2024
1Esophageal Squamous Cell Carcinoma
11/2023
1Mouth Neoplasms (Oral Cancer)
09/2023
1Ischemia
04/2023
1Skin Neoplasms (Skin Cancer)
04/2023
1Diarrhea
04/2023
1Infections
04/2023
1Cholangitis
04/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2023
1Communicable Diseases (Infectious Diseases)
01/2023

Drug/Important Bio-Agent (IBA)

36AntigensIBA
10/2023 - 01/2003
35Peptides (Polypeptides)IBA
05/2024 - 08/2002
15Immune Checkpoint InhibitorsIBA
05/2024 - 01/2016
11Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2007
9HLA Antigens (Human Leukocyte Antigens)IBA
05/2024 - 02/2008
8HLA-A24 AntigenIBA
10/2020 - 08/2002
6SurvivinIBA
02/2020 - 06/2011
6Protein Subunit VaccinesIBA
08/2019 - 02/2005
6HLA-A Antigens (HLA-A)IBA
08/2014 - 12/2002
5Messenger RNA (mRNA)IBA
01/2020 - 01/2009
5EpitopesIBA
04/2019 - 06/2009
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2023 - 01/2016
4Oxidoreductases (Dehydrogenase)IBA
04/2017 - 05/2015
3Aldehyde DehydrogenaseIBA
05/2024 - 01/2016
3Complementary DNA (cDNA)IBA
10/2023 - 08/2004
3Neoplasm Antigens (Tumor Antigens)IBA
06/2023 - 02/2007
3Formaldehyde (Formol)FDA Link
02/2023 - 12/2006
3ParaffinIBA
02/2023 - 12/2006
3Aldehyde Dehydrogenase 1 FamilyIBA
01/2022 - 04/2017
3incomplete Freund's adjuvantIBA
02/2020 - 06/2011
3HLA-B55 antigenIBA
04/2019 - 06/2009
3Histocompatibility Antigens Class IIBA
01/2017 - 05/2015
3HLA-A2 Antigen (HLA A2 Antigen)IBA
08/2014 - 02/2008
3Cancer VaccinesIBA
01/2013 - 04/2009
2Calcibiotic Root Canal SealerIBA
04/2024 - 01/2017
2Odorant Receptors (Odorant Receptor)IBA
09/2023 - 01/2016
2Cisplatin (Platino)FDA LinkGeneric
07/2023 - 01/2023
2Small Interfering RNA (siRNA)IBA
04/2023 - 04/2016
2Differentiation AntigensIBA
04/2023 - 01/2023
2Transcription Factors (Transcription Factor)IBA
04/2023 - 08/2016
2Immune Checkpoint ProteinsIBA
04/2023 - 04/2017
2RNA (Ribonucleic Acid)IBA
01/2023 - 06/2019
2LigandsIBA
11/2021 - 08/2019
2NivolumabIBA
07/2021 - 06/2021
2pembrolizumabIBA
07/2021 - 11/2020
21-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2021 - 01/2019
2Photosensitizing Agents (Photosensitizers)IBA
02/2021 - 01/2019
2B7-H1 AntigenIBA
11/2020 - 04/2017
2Single-Chain AntibodiesIBA
10/2020 - 08/2014
2GemcitabineFDA Link
08/2019 - 10/2018
2DNA (Deoxyribonucleic Acid)IBA
06/2019 - 08/2012
2Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2018 - 04/2014
2Biomarkers (Surrogate Marker)IBA
01/2017 - 01/2013
2Monoclonal AntibodiesIBA
08/2014 - 12/2006
2VaccinesIBA
09/2011 - 04/2009
1AldehydesIBA
05/2024
1NLR ProteinsIBA
11/2023
1eribulinFDA Link
11/2023
1GTP-Binding Proteins (G-Protein)IBA
09/2023
1Interferon-gamma (Interferon, gamma)IBA
06/2023
1CEACAM1 ProteinIBA
04/2023
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
02/2023
1Monophenol Monooxygenase (Tyrosinase)IBA
01/2023
1AntibodiesIBA
01/2023
1mRNA VaccinesIBA
01/2023
1MART-1 AntigenIBA
01/2023
1HLA-A*24:02 antigenIBA
01/2023
1Immunoglobulin G (IgG)IBA
01/2023

Therapy/Procedure

44Immunotherapy
05/2024 - 01/2003
27Therapeutics
10/2023 - 02/2007
14Drug Therapy (Chemotherapy)
05/2024 - 08/2004
7Radiotherapy
05/2024 - 01/2013
2Aftercare (After-Treatment)
03/2021 - 01/2013
1Extracorporeal Membrane Oxygenation
04/2023